Diagnosis, Screening, and Early Detection of Kidney Cancer

• Early kidney cancer often causes no symptoms; when signs do appear, the most common is blood showing up in the urine, sometimes along with a lump or pain in the belly or side.
• Diagnosis usually starts with a physical exam and blood or urine tests, followed by imaging — ultrasound, CT, or MRI — to look for a kidney mass.
• A biopsy can confirm the diagnosis and identify the type of kidney cancer, though it isn’t always needed if imaging findings are clear enough on their own.
• Routine screening isn’t recommended for people at average risk; it’s reserved for those with a hereditary kidney cancer syndrome or long-term dialysis-related kidney disease.
• Because the stage of disease at diagnosis affects both prognosis and treatment options, finding kidney cancer earlier generally widens the range of available treatments.

Early Signs and Symptoms of Kidney Cancer

Kidney cancer frequently causes no symptoms in its early stages, and signs typically appear only as a tumor grows, which makes early detection based on symptoms alone difficult. The most frequently reported sign is blood in the urine, which may be visible or detectable only through testing. Other possible signs include a lump or swelling in the belly or side, ongoing pain in the side or back, reduced appetite, weight loss that isn’t otherwise explained, and anemia. None of these signs are specific to kidney cancer — they can also point to other conditions — but they are a reason to see a health care provider for evaluation.

The Kidney Cancer Diagnosis Process

Reaching a kidney cancer diagnosis generally moves from a general evaluation of symptoms and history to imaging that looks specifically at the kidneys, and then to tissue confirmation. This overview covers the diagnostic path most relevant to adults, for whom renal cell cancer is by far the most frequently diagnosed form; Wilms tumor, a kidney cancer that occurs mainly in young children, follows a different evaluation and treatment path and is covered by the National Cancer Institute as its own topic.

Initial Evaluation and Physical Exam

The process typically begins with a review of personal and family health history and a physical exam. Blood chemistry testing and urinalysis are also commonly ordered: they can reveal unusual levels of substances the kidneys normally filter, as well as blood in the urine that isn’t visible to the eye.

Imaging Tests for Detection

If kidney cancer is suspected, imaging is central to finding and characterizing a kidney mass. These scans can show both cysts and solid tumors in the kidney, which helps a care team tell a usually harmless fluid-filled cyst apart from a mass that needs closer evaluation.

• Ultrasound: Uses sound waves to build a picture of the kidneys and is often the first imaging test used to look at a suspected mass.
• CT scan: Uses x-rays and a computer to create detailed, layered images of the abdomen; a contrast dye is often given so organs and tissues show up more clearly. It is one of the primary tools for detecting a kidney tumor and checking whether it has reached nearby structures.
• MRI: Uses a magnet and radio waves to produce detailed images. It may be used when a CT scan is inconclusive, when contrast dye isn’t an option, or to look more closely at whether a tumor has grown into nearby blood vessels.

Confirming Kidney Cancer Diagnosis

When imaging points to a kidney mass, further steps are usually needed to confirm the diagnosis and characterize the tumor.

Biopsy Procedures

A biopsy involves removing a small tissue sample, usually with a needle guided by ultrasound or CT imaging, so a pathologist can examine it under a microscope. It can confirm whether a mass is cancerous and identify what type of kidney cancer is present — most often renal cell cancer, the form that is most common in adults. A biopsy isn’t always necessary: if imaging findings already give a clear enough picture, a diagnosis may be made without one.

Staging and Grading the Cancer

Once cancer is confirmed, the next step is determining its extent, or stage, most often using the TNM (tumor, node, metastasis) system, which looks at tumor size and whether the cancer has reached lymph nodes or other parts of the body. A pathology report may also note the tumor’s grade — a routine description of how abnormal the cells look under the microscope. Both stage and grade, together with a patient’s age and general health, help guide the treatment plan; what each stage means specifically is covered in more detail on this site’s kidney cancer staging page.

Kidney Cancer Screening Guidelines

There is currently no evidence-based screening test recommended for kidney cancer in people at average risk, and routine screening is not part of standard care for the general population. Targeted screening is instead reserved for two groups known to carry a meaningfully higher risk.

The first group includes people with a hereditary kidney cancer syndrome — for example, Birt-Hogg-Dubé syndrome, hereditary papillary renal cancer, hereditary leiomyomatosis and renal cell cancer, or Von Hippel-Lindau disease; together, these inherited syndromes account for only a small share of all kidney cancers. Families known to carry one of these syndromes are typically monitored closely by a specialist, since the same gene change can also raise the risk of tumors elsewhere in the body, not only the kidneys.

The second group is people with long-term kidney failure who are on dialysis. Prolonged dialysis can lead to acquired cystic kidney disease, and people with this condition are more likely than the general population to develop a kidney tumor. For this reason, some health care providers recommend screening with CT or MRI starting around three years into dialysis, though the right time to begin is a conversation to have with a care team.

Why Early Detection Matters

Both the prognosis and the range of treatment options for kidney cancer depend heavily on the stage at diagnosis, along with a patient’s age and general health. Cancer that is still confined to the kidney at diagnosis is generally associated with a more favorable outlook than cancer found after it has spread beyond the kidney; the specific survival figures for each stage are covered on this site’s kidney cancer survival page, and the treatments available at each stage are covered on the treatment options page. For this reason, prompt evaluation of any of the symptoms described above, along with appropriate screening for those at higher-than-average risk, remains an important part of catching kidney cancer at a more treatable stage.

Frequently Asked Questions

What are the most common initial symptoms of kidney cancer?

The most commonly reported initial sign is blood in the urine, which may be visible or detected only through testing. Other possible symptoms include a lump in the abdomen, pain in the side or back that doesn’t go away, unexplained weight loss, and loss of appetite. None of these are specific to kidney cancer, so see a doctor for an evaluation if they occur.

Are there specific tests to screen for kidney cancer in the general population?

No, there is no standard screening test recommended for people at average risk. Screening is reserved for people with a known hereditary kidney cancer syndrome or those on long-term dialysis, who may be monitored with periodic imaging.

How long does it typically take to get a definitive kidney cancer diagnosis?

The timeline varies from person to person. It depends on how quickly imaging results come back, whether a biopsy is needed, and how soon follow-up tests and specialist appointments can be scheduled. A care team can give a more specific estimate based on an individual situation.

Sources

• National Cancer Institute – Renal Cell Cancer Treatment (PDQ®)–Patient Version
• National Cancer Institute – Kidney (Renal Cell) Cancer—Patient Version
• National Cancer Institute – Hereditary Kidney Cancer Syndromes (PDQ®)–Patient Version
• National Institute of Diabetes and Digestive and Kidney Diseases – Acquired Cystic Kidney Disease